Company / Operating Income
Tyra Biosciences, Inc. Operating Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$104.2M
FY2024
5-year range
-$104.2M / -$9.3M
FY2020-FY2024
Trend
-30.3%
vs FY2023
Sector context
#94 of 204
Health Care
What the data says
At -$104M, Tyra Biosciences, Inc.'s operating income ranks #94 of 204 in the Health Care sector. Operating Income has declined for 4 consecutive years, from -$9M in FY2020 to -$104M in FY2024.
Based on SEC 10-K filings.
-$104M in FY2024.
Declined from -$59M to -$104M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 204 in Health CareTop 46% of 204This company -$104.2M Sector average $107.7M
▼
-196.7% below sector average
Key checks
Key Insights
- Tyra Biosciences, Inc.'s operating income has declined for 4 consecutive years.
- In FY2024, operating income decreased 30.3% year-over-year.
- Ranks #94 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$104.2M | -30.3% |
| FY2023 | -$79.9M | -35.7% |
| FY2022 | -$58.9M | -124.2% |
| FY2021 | -$26.3M | -182.8% |
| FY2020 | -$9.3M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026